Published in HPB (Oxford) on February 01, 2010
Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res (2011) 1.67
Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer (2014) 0.89
Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified? World J Gastroenterol (2013) 0.87
Selection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm. World J Hepatol (2015) 0.83
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82
The role of bridging therapy in hepatocellular carcinoma. Int J Hepatol (2013) 0.79
A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma. Surg Today (2016) 0.76
Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer. Diagnostics (Basel) (2015) 0.75
Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study. United European Gastroenterol J (2016) 0.75
Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience. World J Transplant (2016) 0.75
A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients. Transl Oncol (2016) 0.75
Value of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinoma. Medicine (Baltimore) (2016) 0.75
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol (2016) 0.75
Twenty years of Milan criteria: how far do we go. Hepatobiliary Surg Nutr (2016) 0.75
Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion. Oncotarget (2017) 0.75
Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria. World J Surg (2012) 0.75
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol (2008) 5.24
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg (1995) 2.03
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95
Hepatic transplantation for primary and metastatic cancers of the liver. Surgery (1991) 1.93
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg (1998) 1.90
The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol (2009) 1.67
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg (2002) 1.47
Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33
Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl (2001) 1.31
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut (2002) 1.29
Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg (2001) 1.21
Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol (2008) 1.16
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? Transplant Proc (1997) 0.94
Hepatoma--resection or transplantation. Surg Clin North Am (2004) 0.90
Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg (2005) 0.89
Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg (2003) 0.87
Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Clin Transplant (2007) 0.86
Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc (2006) 0.81
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg (2011) 1.78
Reassortant highly pathogenic influenza A(H5N6) virus in Laos. Emerg Infect Dis (2015) 1.54
Prevalent immunosuppressive strategies in liver transplantation for hepatitis C: results of a multi-center international survey. Transpl Int (2008) 1.45
PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. Anticancer Res (2010) 1.43
Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol (2011) 1.26
Bone disease in patients with primary sclerosing cholangitis. Gastroenterology (2010) 1.15
Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis (2003) 1.07
Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1029 patients. Ann Surg (2009) 1.01
Toward proof of concept of a one health approach to disease prediction and control. Emerg Infect Dis (2013) 1.01
Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation (2008) 0.98
Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data. HPB (Oxford) (2011) 0.97
Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis. World J Surg Oncol (2008) 0.96
Diffuse malignant infiltration of the liver manifesting as a case of acute liver failure. Nat Clin Pract Gastroenterol Hepatol (2008) 0.94
Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways. Anticancer Res (2014) 0.91
Posttransplant diabetes mellitus in liver transplant recipients. Prog Transplant (2006) 0.91
An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm (2008) 0.90
Molecular therapies in hepatocellular carcinoma: what can we target? Dig Dis Sci (2014) 0.89
Seatbelt injury resulting in functional loss of a transplanted kidney. Prog Transplant (2008) 0.88
Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients. Public Health Rep (2010) 0.86
Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells. J Surg Res (2008) 0.84
Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant (2004) 0.84
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation (2004) 0.84
Effects of hyperglycemia on the development of new-onset diabetes after liver transplantation. Prog Transplant (2009) 0.83
Arteriovenous malformation of the pancreas: A case report and review of literature. Int J Angiol (2008) 0.83
Atypical etiology of massive gastrointestinal bleeding: arterio-enteric fistula following enteric drained pancreas transplant. Am Surg (2004) 0.82
Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation. Am J Transplant (2003) 0.82
Transjugular intrahepatic portosystemic shunt to keep vein open. Liver Transpl (2009) 0.82
Abnormal liver tests as an initial presentation of celiac disease. Dig Dis Sci (2007) 0.82
Transplantation of pediatric en bloc cadaver kidneys into adult recipients: a single-center experience. Am Surg (2002) 0.81
ERCP in the management of early versus late biliary leaks after liver transplantation. Int Surg (2006) 0.81
Predicting dry weight in patients with ascites and liver cirrhosis using computed tomography imaging. Hepatogastroenterology (2010) 0.81
Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants. J Invest Surg (2008) 0.80
The use of Dacron graft for cavo-cavostomy in orthotopic liver transplantation. Transplantation (2008) 0.80
Risk factors for 30-day readmissions after hepatectomy: analysis of 2444 patients from the ACS-NSQIP database. J Gastrointest Surg (2014) 0.79
Effect of chronic glucocorticoid therapy and the gender difference on bone mineral density in liver transplant patients. J Surg Res (2006) 0.79
Curcumin has potent liver preservation properties in an isolated perfusion model. Transplantation (2006) 0.79
Resolution of chronic urticaria coincident with vitamin D supplementation. Ann Allergy Asthma Immunol (2012) 0.78
University of Kentucky experience with laparoscopic live donor nephrectomy using two different techniques. Int Surg (2007) 0.78
Transjugular intrahepatic portosystemic shunt migration in patients undergoing liver transplantation. Int Surg (2003) 0.78
Zoonotic emerging infectious disease in selected countries in Southeast Asia: insights from ecohealth. Ecohealth (2010) 0.78
The macrocidins: novel cyclic tetramic acids with herbicidal activity produced by Phoma macrostoma. J Nat Prod (2003) 0.78
Vaginal varices with massive hemorrhage in a patient with nonalcoholic steatohepatitis and portal hypertension: Successful treatment with liver transplantation. Liver Transpl (2008) 0.77
Resistant trichomoniasis: successful treatment with combination therapy. Sex Transm Dis (2011) 0.77
Pancreas transplantation: current status and experience at the University of Kentucky. J Ky Med Assoc (2002) 0.77
Analysis of smoking in patients referred for liver transplantation and its adverse impact of short-term outcomes. J Ky Med Assoc (2007) 0.77
Analysis of morbidity in liver transplant recipients following human albumin supplementation: a retrospective pilot study. Prog Transplant (2006) 0.77
Anomalous pancreatico-biliary junction and gall bladder cancer in response to Matsumoto M, Maruta M, Maeda K, Utsumi T, Sugioka A, Kuroda M (2002) Epithelial cyst of the gallbladder associated with adenocarcinoma. J Hepatobiliary Pancreat Surg 9:389-392. J Hepatobiliary Pancreat Surg (2003) 0.75
Long-term endoscopic management of intrahepatic stones. J Hepatobiliary Pancreat Surg (2003) 0.75
Duodenal drainage during pancreas transplantation. J Am Coll Surg (2007) 0.75
Regarding "the concept of acute care surgery". Surgery (2007) 0.75
Importance of local infection in hepatic artery pseudoaneurysms. Liver Transpl (2008) 0.75
Industry support and sepsis guidelines. Crit Care Med (2007) 0.75
The easiest way to improve the outcome of suboptimal liver grafts. Liver Transpl (2008) 0.75
Recipient outcome following living donor kidney transplantation using kidneys procured laparoscopically. Clin Transplant (2003) 0.75
Orthotopic liver transplantation in hepatocellular carcinoma: comparison of results in incidental and known hepatocellular carcinoma. Int Surg (2006) 0.75
A pharmacoeconomic analysis of liver transplant charges. Prog Transplant (2007) 0.75
Sphincter of Oddi dysfunction and the anomalous pancreaticobiliary junction. J Hepatobiliary Pancreat Surg (2003) 0.75
Direct intranodal lymphangiography for recurrent chylous ascites following liver-kidney transplantation. Liver Transpl (2014) 0.75
Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient. Ann Transplant (2008) 0.75
Thrombectomy and cavocavostomy for inferior vena cava thrombosis and torsion after piggyback liver transplantation. Liver Transpl (2012) 0.75
Hepatobiliary mucinous cystadenoma resulting in biliary obstruction. Am Surg (2015) 0.75
Perioperative and long-term outcomes in octogenarians after kidney transplantation: the US perspective . Clin Nephrol (2016) 0.75
Neuroendocrine Liver Metastasis: Transplant as Part of Multimodality Liver-Directed Therapy-Reply. Arch Surg (2012) 0.75
Liver transplantation for the treatment of nonresectable metastatic duodenal paraganglioma. Transpl Int (2006) 0.75
Simultaneous kidney-pancreas transplantation in a patient with small lymphocytic lymphoma. Transplantation (2003) 0.75